Ipsilateral breast tumor recurrence after breast-conserving therapy

References

• Veronesi U, Cascinelli N, Mariani L et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med.347, 1227–1232 (2002).
   PubMed Web of Science ®Google Scholar
• Jacobson JA, Danforth DN, Cowan KH et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N. Engl. J. Med.332, 907–911 (1995).
   PubMed Web of Science ®Google Scholar
• Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J. Clin. Oncol.14, 1558–1564 (1996).
   PubMed Web of Science ®Google Scholar
• van Dongen JA, Voogd AC, Fentiman IS et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst.92, 1143–1150 (2000).
   PubMedGoogle Scholar
• Veronesi U, Marubini E, Del Vecchio M et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J. Natl. Cancer Inst.87, 19–27 (1995).
   PubMed Web of Science ®Google Scholar
• Poggi MM, Danforth DN, Sciuto LC et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer98, 697–702 (2003).
   PubMed Web of Science ®Google Scholar
• Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med.333, 1456–1461 (1995).
   PubMed Web of Science ®Google Scholar
• Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med.347, 1233–1241 (2002).
   PubMed Web of Science ®Google Scholar
• Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer57, 1717–1724 (1986).
   PubMed Web of Science ®Google Scholar
• Clark RM, McCulloch PB, Levine MN et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl Cancer Inst.84, 683–689 (1992).
   PubMed Web of Science ®Google Scholar
• Clark RM, Whelan T, Levine M et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J. Natl Cancer Inst.88, 1659–1664 (1996).
   PubMedGoogle Scholar
• Liljegren G, Holmberg L, Bergh J et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J. Clin. Oncol.17, 2326–2333 (1999).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann. Oncol.12, 997–1003 (2001).
   PubMed Web of Science ®Google Scholar
• Malmstrom P, Holmberg L, Anderson H et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clincal trial in a population with access to public mammography screening. Eur. J. Cancer39, 1690–1697 (2003).
   PubMed Web of Science ®Google Scholar
• Kurtz JM, Amalric R, Brandone H et al. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer63, 1912–1917 (1989).
   PubMed Web of Science ®Google Scholar
• Recht A, Silen W, Schnitt SJ et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys.15, 255–261 (1988).
   PubMedGoogle Scholar
• DiPaola RS, Orel SG, Fowble BL. Ipsilateral breast tumor recurrence following conservative surgery and radiation therapy. Oncology (Williston Park)8, 59–68 (1994).
   PubMedGoogle Scholar
• Sanghani M, Balk E, Cady B et al. Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool. Am. J. Clin. Oncol.30, 473–480 (2007).
   PubMedGoogle Scholar
• Fisher B, Anderson S, Fisher ER et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet338(8763), 327–331 (1991).
   PubMed Web of Science ®Google Scholar
• Wapnir IL, Anderson SJ, Mamounas EP et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrence in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J. Clin. Oncol.24, 2028–2037 (2006).
   PubMedGoogle Scholar
• Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet366, 2087–2106 (2005).
   PubMed Web of Science ®Google Scholar
• Anderson SJ, Wapnir I, Dignam JJ et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated with breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J. Clin. Oncol.27, 2466–2473 (2009).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Goldstein NS, Wallace M, Kestin L. Molecular evidence demonstrating local treatment failure is the source of distant metastases in some patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys.71, 689–694 (2008).
   PubMedGoogle Scholar
• Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int. J. Radiat. Oncol. Biol. Phys.19, 833–842 (1990).
   PubMed Web of Science ®Google Scholar
• Haffty BG, Carter D, Flynn SD et al. Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int. J. Radiat. Oncol. Biol. Phys.27, 575–583 (1993).
   PubMedGoogle Scholar
• Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int. J. Radiat. Oncol. Biol. Phys.48, 1281–1289 (2000).
   PubMed Web of Science ®Google Scholar
• Huang E, Buchholz TA, Meric F et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer95, 2059–2067 (2002).
   PubMed Web of Science ®Google Scholar
• Krauss DJ, Kestin LL, Mitchell C, Martinez AA, Vicini FA. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int. J. Radiat. Oncol. Biol. Phys.60, 731–740 (2004).
   PubMedGoogle Scholar
• Freedman GM, Anderson PR, Hanlon AL, Eisenberg DF, Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int. J. Radiat. Oncol. Biol. Phys.61, 1328–1336 (2005).
   PubMed Web of Science ®Google Scholar
• Nishimura S, Takahashi K, Akiyama F et al. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis. Breast Cancer12, 112–117 (2005).
   PubMedGoogle Scholar
• Komoike Y, Akiyama F, Iino Y et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer12, 104–111 (2005).
   PubMedGoogle Scholar
• Panet-Raymond V, Truong PT, McDonald RE et al. ‘True recurrence’ versus ‘new primary’: an analysis of ipsilateral breast tumor recurrences after breast conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. (In press).
   Google Scholar
• Sirohi B, Leary A, Johnston SR. Ipsilateral breast tumor recurrence: is there any evidence for benefit of further systemic therapy? Breast J.15, 268–278 (2009).
   PubMedGoogle Scholar
• Offersen BV, Overgaard M, Kroman N, Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother. Oncol.90, 1–13 (2009).
   PubMed Web of Science ®Google Scholar
• Mannino M, Yarnold J. Accelerated partial breast irradiation trials: diversity in rationale and design. Radiother. Oncol.91, 16–22 (2009).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int. J. Radiat. Oncol. Biol. Phys.60, 722–730 (2004).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Antonucci JV, Wallace M et al. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation. Int. J. Radiat. Oncol. Biol. Phys.68, 341–346 (2007).
   PubMed Web of Science ®Google Scholar
• King BL, Love SM. The intraductal approach to the breast: raison d’etre. Breast Cancer Res.8, 206 (2006).
   PubMedGoogle Scholar
• Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1–2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer56, 979–990 (1985).
   PubMed Web of Science ®Google Scholar
• Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br. J. Cancer74, 820–824 (1996).
   PubMed Web of Science ®Google Scholar
• Regitnig P, Moser R, Thalhammer M et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J. Pathol.198, 190–197 (2002).
   PubMedGoogle Scholar
• Goldstein NS, Vicini FA, Hunter S et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am. J. Clin. Pathol.123, 679–689 (2005).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Antonucci JV, Goldstein N et al. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy. Cancer109, 1264–1272 (2007).
   PubMedGoogle Scholar
• Bollet MA, Servant N, Neuvial P et al. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. J. Natl Cancer Inst.100, 48–58 (2008).
   PubMedGoogle Scholar
• McGrath S, Antonucci J, Goldstein N et al. Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation. Am. J. Clin. Oncol.33, 17–22 (2010).
   PubMedGoogle Scholar
• Benson JR, della Rovere GQ. Ipsilateral breast cancer recurrence. Breast17, 12–18 (2008).
   PubMedGoogle Scholar
• Tsutsui S, Ohno S, Murakami S, Kataoka A, Kinoshita J, Hachitanda Y. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Oncol. Rep.9, 793–799 (2002).
   PubMedGoogle Scholar
• Regitnig P, Ploner F, Maderbacher M, Lax SF. Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod. Pathol.17, 597–602 (2004).
   PubMedGoogle Scholar
• Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kestin LL. Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. Am. J. Clin. Pathol.124, 49–57 (2005).
   PubMedGoogle Scholar
• Goldstein NS, Kestin LJ, Vicini FA. Monomorphic epithelial proliferations: characterization and evidence suggesting they are the pool of partially transformed lesions from which some invasive carcinomas arise. Am. J. Clin. Pathol.128, 1023–1034 (2007).
   PubMedGoogle Scholar
• Wirapati P, Sotiriou C, Kunkel S et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res.10, R65 (2008).
   PubMed Web of Science ®Google Scholar
• Normanno N, De Luca A, Carotenuto P, et al. Prognostic applications of gene expression signatures in breast cancer. Oncology77(Suppl. 1), 2–8 (2009).
   PubMed Web of Science ®Google Scholar
• Slaughter DP, Southwick HW, Smejkal W. ‘Field cancerization’ in oral stratified squamous epithelium. Cancer6, 963–968 (1953).
   PubMed Web of Science ®Google Scholar
• Braakhuis BJ, Tabor MP, Kummer A, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter’s concept of field cancerization: evidence and clinical implications. Cancer Res.63, 1727–1730 (2003).
   PubMed Web of Science ®Google Scholar
• Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization: molecular evidence and clinical importance. Breast Cancer Res. Treat.118, 229–239 (2009).
   PubMed Web of Science ®Google Scholar
• Weber F, Shen L, Fukino K et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am. J. Hum. Genet.78, 961–972 (2006).
   PubMed Web of Science ®Google Scholar
• Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res.5, R129–R135 (2003).
   PubMed Web of Science ®Google Scholar
• Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum. Mol. Genet.10, 1907–1913 (2001).
   PubMed Web of Science ®Google Scholar
• Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA297, 2103–2111 (2007).
   PubMed Web of Science ®Google Scholar
• Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet.32, 355–357 (2002).
   PubMed Web of Science ®Google Scholar
• Wapnir IL, Aebi S, Geyer CE et al. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02 and NSABP B-37. Clin. Breast Cancer8, 287–292 (2008).
   PubMedGoogle Scholar